CLINICAL RESEARCH: ACUTE CORONARY SYNDROMES
Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function
Henning Steen, MD*,
Evangelos Giannitsis, MD, FESC, MD*,*,
Simon Futterer*,
Constanze Merten, MD*,
Claus Juenger, MD and
Hugo A. Katus, MD, FESC*
* Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany
Herzzentrum Ludwigshafen, Institut für Biometrie, Ludwigshafen, Germany
Manuscript received January 3, 2006;
revised manuscript received July 19, 2006,
accepted July 23, 2006.
* Reprint requests and correspondence: Dr. Evangelos Giannitsis, Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany (Email: evangelos_giannitsis{at}med.uni-heidelberg.de).
OBJECTIVES: In clinical practice, myocardial infarct size can be estimated non-invasively by nuclear imaging techniques or contrast-enhanced magnetic resonance imaging (CE-MRI). Due to limited availability and high costs, serologic tests are frequently used as an alternative.
BACKGROUND: We examined the ability of a single value of cardiac troponin T (cTnT) 96 h after onset of ST-/non–ST-segment elevation myocardial infarction (STEMI/NSTEMI) to estimate absolute infarct mass.
METHODS: Functional and CE-MRI were conducted on a 1.5-T whole-body system 4 days after STEMI/NSTEMI using gadolinium (0.2 mmol/kg/bw). Infarct sizes were measured employing a specified software (Philips Medical Systems, Best, the Netherlands) and correlated with TnT measurements 96 h after onset of STEMI/NSTEMI.
RESULTS: We enrolled 23 STEMI and 21 NSTEMI patients. Median time delay from onset of symptoms to balloon angioplasty was 6.25 and 9.9 h for STEMI/NSTEMI patients, respectively. Contrast-enhanced magnetic resonance imaging (median 4 days) revealed an absolute mean infarct size of 16.2 g (7.7 to 30.1 g) with a mean ejection fraction of 58% (53% to 63%) and mean stroke volume of 84 ml (75 to 107 ml). Absolute infarct sizes and median cTnT values were larger in STEMI than in NSTEMI (29.3 g [interquartile range (IQR) 16.0 to 53.0] and 1.88 µg/l [IQR 0.7 to 2.57] vs. 8.8 g [IQR 3.3 to 16.4] and 0.83 µg/l [IQR 0.4 to 1.3], both p < 0.02). Linear regression analysis was excellent for STEMI (r = 0.910) and moderate albeit still significant for NSTEMI (r = 0.575).
CONCLUSIONS: A single 96-h cTnT value provides an accurate estimate of absolute infarct mass in myocardial infarction. The ability to quantify and the potential to distinguish effects of novel drug regimens on infarct size make cTnT attractive for routine practice and as a clinical end point.
|
Abbreviations and Acronyms
| | CE-MRI = contrast-enhanced cardiac magnetic resonance imaging | | CK = creatine kinase | | cTnT = cardiac troponin T | | HBDH = hydroxybutyrate dehydrogenase | | IQR = interquartile range | | LDH = lactate | | MRI = magnetic resonance imaging | | NSTEMI = non–ST-segment elevation myocardial infarction | | STEMI = ST-segment elevation myocardial infarction |
|
This article has been cited by other articles:
|
|
|
|
 
A. K. Saenger and A. S. Jaffe
Requiem for a Heavyweight: The Demise of Creatine Kinase-MB
Circulation,
November 18, 2008;
118(21):
2200 - 2206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Steen, C. Merten, S. Refle, R. Klingenberg, T. Dengler, E. Giannitsis, and H. A. Katus
Prevalence of Different Gadolinium Enhancement Patterns in Patients After Heart Transplantation
J. Am. Coll. Cardiol.,
September 30, 2008;
52(14):
1160 - 1167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Jaffe
Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers
Clin. Chem.,
September 1, 2008;
54(9):
1432 - 1442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Daniels, G. A. Laughlin, P. Clopton, A. S. Maisel, and E. Barrett-Connor
Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults: Results From the Rancho Bernardo Study
J. Am. Coll. Cardiol.,
August 5, 2008;
52(6):
450 - 459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chia, F. Senatore, O. C. Raffel, H. Lee, F. J. Th. Wackers, and I.-K. Jang
Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv.,
August 1, 2008;
1(4):
415 - 423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. C. Vasile, L. Babuin, E. Giannitsis, H. A. Katus, and A. S. Jaffe
Relationship of MRI-Determined Infarct Size and cTnI Measurements in Patients with ST-Elevation Myocardial Infarction
Clin. Chem.,
March 1, 2008;
54(3):
617 - 619.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Giannitsis, H. Steen, K. Kurz, B. Ivandic, A. C. Simon, S. Futterer, C. Schild, P. Isfort, A. S. Jaffe, and H. A. Katus
Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T
J. Am. Coll. Cardiol.,
January 22, 2008;
51(3):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F Younger, S. Plein, J. Barth, J. P Ridgway, S. G Ball, and J. P Greenwood
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction
Heart,
December 1, 2007;
93(12):
1547 - 1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
